Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064759747> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2064759747 endingPage "1313" @default.
- W2064759747 startingPage "1307" @default.
- W2064759747 abstract "The standard immunosuppression protocol after liver transplantation (LT) is based on an anticalcineurin (ACN) (tacrolimus or cyclosporine microemulsion) combined with mycophenolate and corticosteroids. Corticosteroids are usually stopped between 6 and 12 months after LT, except for patients whose transplantations were necessitated by autoimmune disease. ACN and mycophenolate must be monitored to verify the dose, with a residual blood assay (for tacrolimus), at 2hours (for cyclosporine microemulsion), or by a simplified area under the curve (for mycophenolate). The first-line treatment for rejection calls for increasing the dosage of tacrolimus (or switching to tacrolimus for patients treated with cyclosporine). Second-line treatment for refractory rejection is corticosteroid bolus (500-1000 mg of methylprednisolone, one to three times). Antibodies blocking the interleukin 2 receptors (basiliximab) or lymphocytes (thymoglobulin) make it possible to reduce the incidence of rejection, decrease corticosteroid doses rapidly and introduce ACN later on (useful in cases of kidney failure). The mTOR inhibitors (sirolimus and everolimus) have different side effects (hyperlipidemia, thrombocytopenia, and pulmonary, cutaneous, and articular events) than ACNs. The absence of any renal or vascular effect is interesting for patients with kidney failure, and the antiproliferative effect can be useful for patients transplanted because of cancer. The current objective of immunosuppression is to reduce the adverse effects (kidney failure, metabolic complications, cancer and infections, in particular, which reduce the survival of patients and grafts), and in the future, to promote the establishment of tolerance that ideally will allow the patient to stop prophylactic immunosuppressant treatment. New chemical agents, capable of acting on new and more specific pathways, are in phase II/III testing." @default.
- W2064759747 created "2016-06-24" @default.
- W2064759747 creator A5031718685 @default.
- W2064759747 date "2009-09-01" @default.
- W2064759747 modified "2023-09-30" @default.
- W2064759747 title "Immunosuppression après transplantation hépatique" @default.
- W2064759747 cites W1765070428 @default.
- W2064759747 cites W1965998244 @default.
- W2064759747 cites W1972672172 @default.
- W2064759747 cites W1975705705 @default.
- W2064759747 cites W1994923815 @default.
- W2064759747 cites W1996853835 @default.
- W2064759747 cites W1999460457 @default.
- W2064759747 cites W2022988780 @default.
- W2064759747 cites W2025926353 @default.
- W2064759747 cites W2031660885 @default.
- W2064759747 cites W2043823466 @default.
- W2064759747 cites W2049464448 @default.
- W2064759747 cites W2055977102 @default.
- W2064759747 cites W2056836310 @default.
- W2064759747 cites W2061355484 @default.
- W2064759747 cites W2065634540 @default.
- W2064759747 cites W2079245143 @default.
- W2064759747 cites W2102619353 @default.
- W2064759747 cites W2107346812 @default.
- W2064759747 cites W2117698357 @default.
- W2064759747 cites W2119784685 @default.
- W2064759747 cites W2127746188 @default.
- W2064759747 doi "https://doi.org/10.1016/j.lpm.2009.06.004" @default.
- W2064759747 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19651486" @default.
- W2064759747 hasPublicationYear "2009" @default.
- W2064759747 type Work @default.
- W2064759747 sameAs 2064759747 @default.
- W2064759747 citedByCount "4" @default.
- W2064759747 countsByYear W20647597472013 @default.
- W2064759747 countsByYear W20647597472023 @default.
- W2064759747 crossrefType "journal-article" @default.
- W2064759747 hasAuthorship W2064759747A5031718685 @default.
- W2064759747 hasConcept C126322002 @default.
- W2064759747 hasConcept C126894567 @default.
- W2064759747 hasConcept C141071460 @default.
- W2064759747 hasConcept C2776760755 @default.
- W2064759747 hasConcept C2777630719 @default.
- W2064759747 hasConcept C2777921159 @default.
- W2064759747 hasConcept C2779134260 @default.
- W2064759747 hasConcept C2779699572 @default.
- W2064759747 hasConcept C2780252810 @default.
- W2064759747 hasConcept C2780303639 @default.
- W2064759747 hasConcept C2780372218 @default.
- W2064759747 hasConcept C2781307858 @default.
- W2064759747 hasConcept C2909675724 @default.
- W2064759747 hasConcept C2911091166 @default.
- W2064759747 hasConcept C71924100 @default.
- W2064759747 hasConcept C90924648 @default.
- W2064759747 hasConceptScore W2064759747C126322002 @default.
- W2064759747 hasConceptScore W2064759747C126894567 @default.
- W2064759747 hasConceptScore W2064759747C141071460 @default.
- W2064759747 hasConceptScore W2064759747C2776760755 @default.
- W2064759747 hasConceptScore W2064759747C2777630719 @default.
- W2064759747 hasConceptScore W2064759747C2777921159 @default.
- W2064759747 hasConceptScore W2064759747C2779134260 @default.
- W2064759747 hasConceptScore W2064759747C2779699572 @default.
- W2064759747 hasConceptScore W2064759747C2780252810 @default.
- W2064759747 hasConceptScore W2064759747C2780303639 @default.
- W2064759747 hasConceptScore W2064759747C2780372218 @default.
- W2064759747 hasConceptScore W2064759747C2781307858 @default.
- W2064759747 hasConceptScore W2064759747C2909675724 @default.
- W2064759747 hasConceptScore W2064759747C2911091166 @default.
- W2064759747 hasConceptScore W2064759747C71924100 @default.
- W2064759747 hasConceptScore W2064759747C90924648 @default.
- W2064759747 hasIssue "9" @default.
- W2064759747 hasLocation W20647597471 @default.
- W2064759747 hasLocation W20647597472 @default.
- W2064759747 hasOpenAccess W2064759747 @default.
- W2064759747 hasPrimaryLocation W20647597471 @default.
- W2064759747 hasRelatedWork W1862437987 @default.
- W2064759747 hasRelatedWork W2032759048 @default.
- W2064759747 hasRelatedWork W2050221135 @default.
- W2064759747 hasRelatedWork W2057366582 @default.
- W2064759747 hasRelatedWork W2064759747 @default.
- W2064759747 hasRelatedWork W2078562396 @default.
- W2064759747 hasRelatedWork W2087821141 @default.
- W2064759747 hasRelatedWork W3010430700 @default.
- W2064759747 hasRelatedWork W3119545572 @default.
- W2064759747 hasRelatedWork W4239099985 @default.
- W2064759747 hasVolume "38" @default.
- W2064759747 isParatext "false" @default.
- W2064759747 isRetracted "false" @default.
- W2064759747 magId "2064759747" @default.
- W2064759747 workType "article" @default.